COVID-19 Battle: Everest Organics develops Remdesivir API
Advertisement
Mumbai: Pharma major, Everest Organics on Monday said that Remdesivir API has been successfully developed in the R & D facility of the company.
Commenting on the R&D success of EOL team, Dr Sirisha Srikakarlapudi, Director, EOL - New Product Development said, "lt's a moment of utmost satisfaction that with hard work of the past few months by Everest Organics R&D team, we have been able to successfully develop Remdesivir API at lab scale in a short span of time.'
'The development of Remdesivir API by Everest Organics Limited is the outcome of investments we've made in R&D over the period of the last few years, which further helped strengthening technical expertise. Infact we are poised for the development of more products in the Anti-Viral segments in the future"Mr Srikakarlapudi added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.